Lemaitre Vascular [LMAT] vs Becton, Dickinson [BDX] Detailed Stock Comparison
Lemaitre Vascular
NASDAQ
Loading...
Becton, Dickinson
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Lemaitre Vascular wins in 8 metrics, Becton, Dickinson wins in 12 metrics, with 0 ties. Becton, Dickinson appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lemaitre Vascular | Becton, Dickinson | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 45.48 | 36.04 | Becton, Dickinson |
| Price-to-Book Ratio | 6.06 | 2.11 | Becton, Dickinson |
| Debt-to-Equity Ratio | 53.33 | 76.34 | Lemaitre Vascular |
| PEG Ratio | 42.96 | 11.82 | Becton, Dickinson |
| EV/EBITDA | 31.65 | 12.20 | Becton, Dickinson |
| Profit Margin (TTM) | 19.96% | 7.18% | Lemaitre Vascular |
| Operating Margin (TTM) | 21.09% | 16.01% | Lemaitre Vascular |
| EBITDA Margin (TTM) | 21.09% | 16.01% | Lemaitre Vascular |
| Return on Equity | 13.77% | 5.89% | Lemaitre Vascular |
| Return on Assets (TTM) | 7.28% | 3.69% | Lemaitre Vascular |
| Free Cash Flow (TTM) | $37.16M | $3.07B | Becton, Dickinson |
| Dividend Yield | 0.98% | 1.80% | Becton, Dickinson |
| 1-Year Return | 10.17% | -17.97% | Lemaitre Vascular |
| Price-to-Sales Ratio (TTM) | 9.33 | 2.55 | Becton, Dickinson |
| Enterprise Value | $1.99B | $68.00B | Becton, Dickinson |
| EV/Revenue Ratio | 8.79 | 3.26 | Becton, Dickinson |
| Gross Profit Margin (TTM) | 69.18% | 42.81% | Lemaitre Vascular |
| Revenue per Share (TTM) | $10 | $72 | Becton, Dickinson |
| Earnings per Share (Diluted) | $2.05 | $5.16 | Becton, Dickinson |
| Beta (Stock Volatility) | 0.79 | 0.22 | Becton, Dickinson |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lemaitre Vascular vs Becton, Dickinson Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lemaitre Vascular | -2.10% | 13.87% | 9.97% | 13.23% | -6.26% | 0.89% |
| Becton, Dickinson | 3.10% | 9.71% | 10.81% | 15.21% | -15.70% | -14.57% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lemaitre Vascular | 10.17% | 68.46% | 225.16% | 578.03% | 1,438.00% | 1,330.70% |
| Becton, Dickinson | -17.97% | -26.61% | -23.17% | 33.78% | 179.52% | 265.18% |
Performance & Financial Health Analysis: Lemaitre Vascular vs Becton, Dickinson
| Metric | LMAT | BDX |
|---|---|---|
| Market Information | ||
| Market Cap | $2.11B | $53.31B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 164,230 | 2,491,688 |
| 90 Day Avg. Volume | 135,537 | 2,881,043 |
| Last Close | $92.28 | $193.50 |
| 52 Week Range | $71.42 - $109.58 | $163.33 - $251.99 |
| % from 52W High | -15.79% | -23.21% |
| All-Time High | $109.58 (Nov 25, 2024) | $287.32 (Jul 24, 2023) |
| % from All-Time High | -15.79% | -32.65% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.12% | 0.05% |
| Quarterly Earnings Growth | 0.11% | -0.43% |
| Financial Health | ||
| Profit Margin (TTM) | 0.20% | 0.07% |
| Operating Margin (TTM) | 0.21% | 0.16% |
| Return on Equity (TTM) | 0.14% | 0.06% |
| Debt to Equity (MRQ) | 53.33 | 76.34 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $15.38 | $88.07 |
| Cash per Share (MRQ) | $13.39 | $2.38 |
| Operating Cash Flow (TTM) | $48.09M | $3.30B |
| Levered Free Cash Flow (TTM) | $29.00M | $3.50B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.98% | 1.80% |
| Last 12-Month Dividend | $0.92 | $3.03 |
Valuation & Enterprise Metrics Analysis: Lemaitre Vascular vs Becton, Dickinson
| Metric | LMAT | BDX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 45.48 | 36.04 |
| Forward P/E | 42.96 | 11.82 |
| PEG Ratio | 42.96 | 11.82 |
| Price to Sales (TTM) | 9.33 | 2.55 |
| Price to Book (MRQ) | 6.06 | 2.11 |
| Market Capitalization | ||
| Market Capitalization | $2.11B | $53.31B |
| Enterprise Value | $1.99B | $68.00B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.79 | 3.26 |
| Enterprise to EBITDA | 31.65 | 12.20 |
| Risk & Other Metrics | ||
| Beta | 0.79 | 0.22 |
| Book Value per Share (MRQ) | $15.38 | $88.07 |
Financial Statements Comparison: Lemaitre Vascular vs Becton, Dickinson
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LMAT | BDX |
|---|---|---|
| Revenue/Sales | $59.87M | $5.27B |
| Cost of Goods Sold | $18.45M | $3.02B |
| Gross Profit | $41.42M | $2.26B |
| Research & Development | $4.10M | $302.00M |
| Operating Income (EBIT) | $12.63M | $637.00M |
| EBITDA | $18.08M | $1.21B |
| Pre-Tax Income | $14.24M | $363.00M |
| Income Tax | $3.23M | $55.00M |
| Net Income (Profit) | $11.01M | $308.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LMAT | BDX |
|---|---|---|
| Cash & Equivalents | $25.34M | $667.00M |
| Total Current Assets | $408.11M | $8.67B |
| Total Current Liabilities | $24.75M | $7.69B |
| Long-Term Debt | $182.73M | $17.67B |
| Total Shareholders Equity | $347.57M | $25.24B |
| Retained Earnings | $151.58M | $16.15B |
| Property, Plant & Equipment | $41.34M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LMAT | BDX |
|---|---|---|
| Operating Cash Flow | $5.69M | $941.00M |
| Capital Expenditures | $-1.38M | N/A |
| Free Cash Flow | $7.66M | $35.00M |
| Debt Repayment | N/A | $-1.00M |
| Common Stock Repurchase | N/A | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | LMAT | BDX |
|---|---|---|
| Shares Short | 1.38M | 4.69M |
| Short Ratio | 9.42 | 1.49 |
| Short % of Float | 0.08% | 0.02% |
| Average Daily Volume (10 Day) | 164,230 | 2,491,688 |
| Average Daily Volume (90 Day) | 135,537 | 2,881,043 |
| Shares Outstanding | 22.55M | 289.10M |
| Float Shares | 20.65M | 285.93M |
| % Held by Insiders | 0.09% | 0.01% |
| % Held by Institutions | 0.96% | 0.93% |
Dividend Analysis & Yield Comparison: Lemaitre Vascular vs Becton, Dickinson
| Metric | LMAT | BDX |
|---|---|---|
| Last 12-Month Dividend | $0.92 | $3.03 |
| Last 12-Month Dividend Yield | 0.98% | 1.80% |
| 3-Year Avg Annual Dividend | $0.68 | $3.16 |
| 3-Year Avg Dividend Yield | 0.23% | 0.40% |
| 3-Year Total Dividends | $2.04 | $9.48 |
| Ex-Dividend Date | Aug 21, 2025 | Mar 10, 2025 |